Accepted at 11:52 p.m. Oct, 31, 2023 by dollajas
Author: Ahmed7
Related Note: 1514576041266
Rationale for change

need help with wording this, maintainers feel free to make changes as you see fit, also what to do with the "no longer" give prophylactic treatment since you do in certain situations, also maybe we can add asterisk after the none?

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Microbiology::HIV_infection_management #AK_Step2_v12::#Resources_by_rotation::IM::amboss_medicalark #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::14_Macrolides #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::02_Inhibitors_of_Bacterial_Protein_Synthesis::02_Macrolides #AK_Step2_v12::#FirstAid::14_Pulm::07_Mycobacterial_Infections::02_Nontuberculous_Mycobacteria #AK_Step2_v12::#Resources_by_rotation::IM::ome::infection::hiv #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::16_Macrolides #AK_Step2_v12::#B&B::08_Infectious_Disease::03_HIV::03_HIV_Complications::Extra #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Rifamycins #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Avium_Complex::Prophylaxis #AK_Step2_v12::Original_decks::Dorian::im::ome::infection::hiv #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::HIV_infection_management #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::22_Dapsone,_Rifamycins,_Clofazimine_(Leprosy_Drugs) #PANCE::INFECTIOUS_DISEASE::mycobacterial_diseases #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Avium_Complex #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::03_Antimycobacterials::02_Leprosy_Drugs::zanki_extra #AK_Step2_v12::#UWorld::COMLEX::100060 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#UWorld::Step::3252 #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::23_Rifamycins #AK_Step1_v12::#Bootcamp::Microbiology::35_Opportunistic_Infections::07_Cytomegalovirus,_Disseminated_Mycobacterial_Non-Tuberculous_Disease #AK_Step2_v12::#B&B::08_Infectious_Disease::03_HIV::01_HIV_Infection::Extra #AK_Step2_v12::#AMBOSS::IF0Yj3 #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::27_Antimycobacterial_therapy #AK_Other::!AK_UpdateTags::Table::HIV_Opportunistic_Prophylaxis #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#SketchyMicro::01_Bacteria::08_Mycobacteria::03_Mycobacterium_avium_intracellulare,_Mycobacterium_scrofulaceum,_Mycobacterium_marinum #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::Retired_Lessons::04_HIV_&_AIDS::02_AIDS_SOAP_[OLD_VERSION] #AK_Step1_v12::#B&B::14_Infectious_Disease::02_Bacteria::08_Mycobacteria #AK_Step2_v12::Original_decks::MedicalArk::im::amboss #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_2::Antibacterials::Antimycobacterials #AK_Step1_v12::^Other::^EXPN